New Clinical Tips for a Definitive Mesothelioma Diagnosis

New Clinical Tips for a Definitive Mesothelioma Diagnosis

Researchers at Ohio State University published new tips for a definitive mesothelioma diagnosis. The team says three different tools are important for getting the right answer. One of the biggest challenges with mesothelioma is just getting a definitive diagnosis. Mesothelioma is closely associated with asbestos. But symptoms may not show up until decades after the exposure. This makes it difficult to link the cause and effect. When symptoms such occur, they are often attributed to other, less serious causes. But a recent article in Diagnostic Cytopathology focuses on promising new diagnostic tips. Tips on Using 3 Different Diagnostic Tools Together For this case study, a single 63-year-old patient was used as an example. The team used a combination of tools … Continue reading New Clinical Tips for a Definitive Mesothelioma Diagnosis »

Latest Classification Updates for Mesothelioma In Situ

Classification Updates for Mesothelioma In Situ

There are new guidelines on the diagnosis and classification of mesothelioma in situ. A new article in the Journal of Cancer Metastasis and Treatment talks about why these updates are important. The latest updates were first published by the World Health Organization (WHO). The previous WHO classification of pleural mesothelioma included three histological subtypes. But WHO recently recognized mesothelioma in situ as a fourth mesothelioma subtype. Pathologists can tell the difference between the subtypes by looking at the cells under a microscope. Each subtype has a slightly different cell shape, growth pattern, and nuclear characteristics. The fourth mesothelioma subtype is a very early form of mesothelioma. Previous studies suggest that it may be an early sign of mesothelioma. If patients … Continue reading Latest Classification Updates for Mesothelioma In Situ »

High-Resolution Imaging for Mesothelioma Staging and Diagnosis

High-Resolution Imaging for Mesothelioma Staging and Diagnosis

High-resolution imaging is one of the most important tools for a clinician. A new report in the AME Surgical Journal shows the importance of better clinical imaging. It is key for accurate diagnosis and staging of malignant mesothelioma. Malignant pleural mesothelioma is a complex disease. Mesothelioma diagnosis and accurate staging are often difficult to pin down. And the diagnosis is further complicated by different disease subtypes. Higher resolution diagnostic imaging plays an important role in diagnosis and staging. It shows tumor thickness or volumetric data. Future updates to the cancer staging system may use clinical imaging benchmarks. Importance and Use of Clinical Imaging Mesothelioma causes significant morbidity and mortality. And it remains a challenging disease to diagnose and stage accurately. … Continue reading High-Resolution Imaging for Mesothelioma Staging and Diagnosis »

Predicting Survival in Patients with Malignant Pleural Mesothelioma

Predicting Survival in Patients with Malignant Pleural Mesothelioma

Researchers found a new way of predicting survival in malignant pleural mesothelioma patients. The prognostic model takes information from the health record to predict survival. Mesothelioma is a rare form of cancer caused by exposure to asbestos. The new prognostic model can help doctors decide on the best treatment plan. This is important for newly-diagnosed patients. And it will have a big impact on their prognosis and quality of life. Many factors can affect a malignant mesothelioma prognosis. Some relate to the patient’s overall health and disease stage or type. While others have to do with the type of treatment the patient undergoes. Several prognostic models have been developed for mesothelioma. These all include information from the patient’s record. And … Continue reading Predicting Survival in Patients with Malignant Pleural Mesothelioma »

The RARECARE Project: An International Network Includes Mesothelioma

The RARECARE Project: An International Network Includes Mesothelioma

The RARECARE Project is a network of international clinicians who support rare tumor patients. This includes malignant mesothelioma, the asbestos-caused cancer. RARECARE wants to ensure access to clinical trials. And to the second opinion of cancer specialists. They are working towards guaranteeing equal health care access and better care management. Humble Beginnings In 2008, the European Commission started the RARECARE project. It is a cancer registry with patient data. They are trying to define the incidence, prevalence, and outcome of rare cancers. Soon, the RARECARE registry led to a second project, RARECAREnet. This updated and enlarged the available information on rare cancers in Europe. Mesothelioma remains one of the rarest of rare cancers. It is more common in the UK … Continue reading The RARECARE Project: An International Network Includes Mesothelioma »

New Tool Measures Past Exposure to Asbestos

New Tool Measures Past Exposure to Asbestos

A new Italian study supports the most reliable tool for determining past exposure to asbestos. The study has confirmed what thousands of mesothelioma patients already know. Exposure to asbestos puts them at high risk for malignant mesothelioma. Asbestos is a naturally occurring mineral that has been found throughout the world. It was once called the “magic mineral” because of its seemingly magical properties. Because of its heat-resistant properties, it served as an insulator in factories, schools, homes, and ships. Thousands of workers have come in contact with the material daily, in some cases, for decades. Asbestos is toxic and cancer-causing for human beings. It causes mesothelioma and other asbestos-related diseases. Generally, those who develop asbestos-related diseases show no signs of … Continue reading New Tool Measures Past Exposure to Asbestos »

Major Effect of COVID-19 on Mesothelioma Patient Survival in Italy

Major Effect of COVID-19 on Mesothelioma Patient Survival in Italy

The COVID‐19 pandemic had a major effect on some mesothelioma patients in Italy. A new study in Medical & Clinical Research shows how the pandemic harmed new diagnoses and survival. Malignant mesothelioma is one of the rarest types of cancer. Many people have never even heard of ‘asbestos cancer’ until they are diagnosed. Most do not know anyone else who has it. Social distancing to protect themselves against COVID-19 compounds the problem. The timely diagnosis of mesothelioma is important. Although it may not change the prognosis of the disease, it can help in treatment strategies. Treatment delays due to the COVID-19 pandemic had a major effect on survival rates for some patients. Survival Rate during Pandemic During the COVID-19 pandemic, … Continue reading Major Effect of COVID-19 on Mesothelioma Patient Survival in Italy »

Localized Mesothelioma Successfully Treated with Chemotherapy and Surgery

A patient with a rare, localized malignant pleural mesothelioma has been successfully treated. The patient received chemotherapy and surgery and has been disease-free for 12 months. Many believe that a localized form of pleural mesothelioma might have a better survival outlook. This is compared with patients who have the more common, diffuse variety. This latest report comes from a Japanese team of thoracic surgeons. Local vs. Diffuse Mesothelioma Malignant mesothelioma is a rare cancer affecting an estimated 2,500 Americans annually. All forms of mesothelioma have been linked to asbestos exposure. Malignant pleural mesothelioma is the most common form of malignant mesothelioma. Most pleural mesothelioma patients have a type of cancer that tends to spread quickly. It spreds across the thin membrane … Continue reading Localized Mesothelioma Successfully Treated with Chemotherapy and Surgery »

Earlier Mesothelioma Diagnosis with Machine Learning Model

Earlier Mesothelioma Diagnosis with Machine Learning Model

A new machine learning model can diagnose mesothelioma better than any current model. The model provides new hope for early diagnosis and better treatment of malignant mesothelioma. A machine learning tool is a computer program that gets “smarter” the more it runs. One challenge in predicting mesothelioma is that mesothelioma is very rare. With the exception of mesothelioma specialists, most doctors never even see a single case. The same is true for pathologists. If they do not see mesothelioma patients, they are less likely to see differences that may influence the diagnosis. Doctors trained the new machine learning tool to recognize and diagnose malignant mesothelioma. It works more quickly and accurately. Earlier mesothelioma diagnosis would allow for earlier intervention. This … Continue reading Earlier Mesothelioma Diagnosis with Machine Learning Model »

Prognostic Factors Forecast the Future for Women with Mesothelioma

Prognostic Factors Forecast the Future for Women with Mesothelioma

A new study in the World Journal of Surgical Oncology examines mesothelioma prognostic factors. Prognostic factors are measurable traits that can be used to estimate the chance of recovery. They can also measure the chance of mesothelioma recurring or coming back. In other words, prognostic factors can help predict the course of the disease and the future outcome. Prognostic factors are available at the time of diagnosis. They can include patient characteristics such as age, ethnicity, sex, or smoking status. And they also include disease characteristics such as disease stage or type. For mesothelioma, they may even involve the amount of asbestos exposure. The key to prognostic factors is that they must be measurable. Clinicians need a number, or a … Continue reading Prognostic Factors Forecast the Future for Women with Mesothelioma »

Get your free copy of
“Surviving Mesothelioma” Today!